Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a telemedicine program help people with HIV and addiction in alabama?

NCT ID NCT06370481

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 35 times

Summary

This pilot study will test whether a telemedicine program for substance use disorder is feasible and acceptable for 30 people living with HIV in Alabama. Participants will receive addiction care via telemedicine or standard in-person care. The main goal is to see if they attend follow-up visits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Alabama at Birmingham

    RECRUITING

    Birmingham, Alabama, 35294, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

telemedicine

What this could lead to

If successful, this could show that telemedicine is a practical way to deliver addiction care to people with HIV in rural areas.

What could go wrong

This is a very small pilot study (30 people) testing only feasibility, not effectiveness. It may not prove that telemedicine improves health outcomes.

Conditions

The condition(s) this trial relates to.

AIDS disease HIV infectious disease opiate dependence substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.